Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Oscar Bladh, Ulrika Marking, Sebastian Havervall, Nina Greilert‐Norin, Katherina Aguilera, Sophia Hober, Anna Smed‐Sörensen, Max Gordon, Kim Blom, Mikael Åberg, Jonas Klingström, Charlotte Thålin
Abstract
Supplementary appendix This appendix formed part of the original submission. We post it as supplied by the authors. Supplement to: Bladh O, Marking U, Havervall S, et al. Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose. Lancet Microbe 2023; published online April 19. https://doi.org/10.1016/S2666-5247(23)00102-7
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Immune systemVirologyMedicine2019-20 coronavirus outbreakImmunologyInfectious disease (medical specialty)OutbreakInternal medicineDiseaseSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisIntramuscular injections and effects